Development of Schamberg's disease after SARS‐CoV‐2 vaccination

Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 w...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cutaneous immunology and allergy 2022-10, Vol.5 (5), p.192-193
Main Authors: Morimoto, Hiroki, Ogura, Yasuaki, Otsuka, Masaki, Hayano, Satoshi, Tokura, Yoshiki
Format: Article
Language:English
Subjects:
Conflicts of interest
Correspondence
COVID-19 vaccines
Immunization
Purpura
Severe acute respiratory syndrome coronavirus 2
Skin diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Schamberg's disease is one of a group of pigmented purpura diseases. We report a 43‐year‐old woman, who developed Schamberg’s disease after SARS‐CoV‐2 vaccination. Three days after vaccination, a purpuric eruption occurred on the lower extremities, extending to the buttocks, and subsided in 4 weeks. No recurrence was observed thereafter. It is suggested that the vaccination triggered the development of the eruption, which was not merely coincidental. SARS‐CoV‐2 vaccination may stimulate a certain population of T cells, resulting in the development of pigmented purpuric dermatoses.
ISSN:2574-4593
2574-4593
DOI:10.1002/cia2.12247